Rukobia (fostemsavir)

pCPA File Number: 22371
Negotiation Status:
Concluded without agreement
Indication(s):
For use in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen due to resistance, intolerance or safety considerations
Sponsor/Manufacturer:
ViiV Healthcare
CDA-AMC Project Number:
SR0760
pCPA Engagement Letter Issued:
Negotiation Process Concluded: